Inactive Instrument

News DMS Swiss Exchange

Stocks

OXDGM

FR0000063224

Advanced Medical Equipment & Technology

All News

09-14	DMS sees revenue slip, but profitability improves
09-14	Diagnostic Medical Systems S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
07-20	DMS Group reports sequential improvement in second-quarter revenue
07-20	Diagnostic Medical Systems : Q2 2026 REVENUE: EUR 12.2 MILLION	AT
07-02	Diagnostic Medical Systems : HALF-YEAR REPORT ON THE LIQUIDITY CONTRACT ON JUNE 30, 2026	AT
06-22	Diagnostic Medical Systems Group Announces Appointment of Vladislav Tcaci as Director	CI
06-22	DMS strengthens its governance with Bpifrance joining the board
06-22	Diagnostic Medical Systems : DMS GROUP STRENGTHENS ITS GOVERNANCE: APPOINTMENT OF BPIFRANCE INVESTISSEMENT AS A BOARD DIRECTOR	AT
06-21	Diagnostic Medical Systems Sa Announces Appointment of Bpifrance Investissement as Director to Board	CI
06-15	Diagnostic Medical Systems S.A. authorizes a Buyback Plan.	CI
06-15	Diagnostic Medical Systems S.A. announces an Equity Buyback for 2,668,679 shares, representing 10% for ?6.67 million.	CI
06-11	Oddo BHF Applauds Certification of DMS Group's Onyx Product
06-11	Diagnostic Medical Systems Gets EU Medical Device Regulation Certification for Mobile Radiology System	MT
06-10	Diagnostic Medical Systems Obtains Marketing Authorization For Its New ONYX Radiology Mobile	CI
06-10	DMS Group secures European green light
06-10	Diagnostic Medical Systems : DMS GROUP OBTAINS MARKETING AUTHORIZATION FOR ITS NEW ONYX RADIOLOGY MOBILE	AT
06-02	Diagnostic Medical Systems Receives First Drawdown from EUR20 Million Financing	MT
06-01	DMS secures 4 million euros from the EIB
06-01	Diagnostic Medical Systems : DMS GROUP RECEIVES EUR 4 MILLION FROM THE EUROPEAN INVESTMENT BANK, 1ST DRAWDOWN OF THE TOTAL FINANCING OF EUR 20 MILLION	AT
04-21	Diagnostic Medical Systems Reports Unaudited Consolidated Revenue Results for the First Quarter Ended March 31, 2026	CI
04-21	Diagnostic Medical Systems Provides Financial Guidance for the Second Quarter and Full Year of 2026	CI
04-21	Q1 2026 REVENUE: EUR 10 MILLION	PU
04-21	DMS Group anticipates a return to growth in the second quarter of 2026
04-21	21/04/2026 - Q1 2026 Revenue: €10 Million	PU
04-21	Diagnostic Medical Systems : Q1 2026 REVENUE: EUR 10 MILLION	AT